Therapeutic Asset Ratings

13,145 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer Trigeminal Autonomic Cephalalgia	Beijing Tiantan Hospital	P2	B (57)
Immunoglobulin Half-Ig G1-Kappa/Scfv-H-Ch2-Ch3, Anti-(Homo Sapiens Ctla4 (Cytotoxic T-Lymphocyte-Associated Protein 4, Cd152)) And Anti-(Homo Sapienspdcd1 (Programmed Cell Death 1, Pd-1, Pd1, Cd279)), Monoclonal Antibody, Bispecific Neuroendocrine Carcinoma	M.D. Anderson Cancer Center	P2	B (57)
Immunoglobulin Half-Ig G1-Kappa/Scfv-H-Ch2-Ch3, Anti-(Homo Sapiens Ctla4 (Cytotoxic T-Lymphocyte-Associated Protein 4, Cd152)) And Anti-(Homo Sapienspdcd1 (Programmed Cell Death 1, Pd-1, Pd1, Cd279)), Monoclonal Antibody, Bispecific Small Cell Lung Carcinoma	M.D. Anderson Cancer Center	P2	B (57)
Imtenan Oil Radiodermatitis	German University in Cairo	P2	B (57)
Incobotulinumtoxina Neuropathy, Painful	Merz Therapeutics GmbH	P2	B (57)
Indocyanine Green Cholecystitis	University of Florida	P2	B (57)
Inotuzumab Ozogamicin Precursor B-Cell Acute Lymphoblastic Leukemia	First Affiliated Hospital of Zhejiang University	P2	B (57)
ins018_055 Idiopathic Pulmonary Fibrosis	InSilico Medicine Hong Kong Limited	P2	B (57)
Ipilimumab Acral Lentiginous Melanoma	Emory University	P2	B (57)
Ipilimumab Biliary Tract Cancer	Olivia Newton-John Cancer Research Institute	P2	B (57)
Ipilimumab Urinary Bladder Carcinoma	M.D. Anderson Cancer Center	P2	B (57)
Ipilimumab Ewing Sarcoma	Children's National Research Institute	P2	B (57)
Ipilimumab Hepatoblastoma	Children's National Research Institute	P2	B (57)
Ipilimumab Malignant Glioma	National Cancer Institute (NCI)	P2	B (57)
Ipilimumab Neuroendocrine Neoplasm	Olivia Newton-John Cancer Research Institute	P2	B (57)
Ipilimumab Childhood Malignant Neoplasm	Children's National Research Institute	P2	B (57)
Irinotecan Rectal Neoplasm	Pei-Rong Ding	P2	B (57)
Istradefylline Cognitive Disorder	Virginia Commonwealth University	P2	B (57)
Jcar-017 Cd19-Specific Chimeric Antigen Receptor Lymphoma	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	P2	B (57)
k-877 Metabolic Dysfunction-Associated Steatohepatitis	Kowa Research Institute, Inc.	P2	B (57)
Kdt-3594 Parkinson Disease	Kissei Pharmaceutical Co., Ltd.	P2	B (57)
L-Acetyl Carnitine Type 2 Diabetes Mellitus	Khyber Medical University Peshawar	P2	B (57)
Lacosamide Postherpetic Neuralgia	CMH Kharian Medical College	P2	B (57)
Lapatinib Colorectal Cancer	Fudan University	P2	B (57)
lb54640 Acquired Hypothalamic Obesity	Rhythm Pharmaceuticals, Inc.	P2	B (57)

Showing 3176 to 3200 of 13,145 assets

PreviousPage 128 of 526Next